It appears that venture capital investment in biopharmaceutical companies still has not been impacted yet by the COVID-19 pandemic, given the number of large financings announced in recent weeks, but it remains to be seen how long the novel coronavirus will keep businesses from operating as usual.
[Sidebar#SC142312]






